BRIEF-ImmunoCellular Therapeutics Says Has Been Exploring Strategic Opportunities
BRIEF-ImmunoCellular Therapeutics Says Has Been Exploring Strategic Opportunities
簡介-免疫細胞治療公司表示一直在探索戰略機遇
Aug 13 (Reuters) - ImmunoCellular Therapeutics Ltd :
* IMMUNOCELLULAR THERAPEUTICS PROVIDES CORPORATE UPDATE AND REPORTS SECOND QUARTER 2018 FINANCIAL RESULTS
* Q2 LOSS PER SHARE $0.01
* ONGOING EXPLORATION OF STRATEGIC OPPORTUNITIES
* CONTINUED PROGRESS IN STEM-TO-T-CELL PROGRAM
Source text for Eikon: Further company coverage:
((Reuters.Briefs@thomsonreuters.com;)
路透8月13日電-免疫細胞治療有限公司:
*免疫細胞治療公司提供公司最新情況並報告2018年第二季度財務業績
*第二季度每股虧損0.01美元
*持續探索戰略機遇
*STEM-to-T-cell計劃繼續取得進展
Eikon的源文本:進一步的公司報道:
(Reurs.Briefs@thomsonreurs.com;)
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。